The PI3K/PTEN/Akt/mTORC1 pathway is frequently upregulated in T-ALL, The effects of the novel allosteric Akt inhibitor, MK-2206, on a panel of human T-ALL cell lines and primary cells from T-ALL patients were examined. Here, PTEN is linked to acute lymphoblastic leukemia.